Graphic version of this page | Change how these pages look
Home←Clinical support←Formulary←Becavizumab (Avastin)
Becavizumab (Avastin)
- Traffic Light
Grey
- BNF
8.1.5
- Licensed Indicators
Cytotoxic Drugs. NICE not recommended
- Reference
- Criteria
- Provisional
No
Do you want to add this to your CPD record?
Did you find this page helpful?
© 2024
Website by Sitekit, body system icons designed by Freepik